Эрик Тополь - Искусственный интеллект в медицине. Как умные технологии меняют подход к лечению

Jha, S., “To put this in perspective. Your ATM card works in Outer Mongolia, but your EHR can’t be used in a different hospital across the street.” Twitter, 2017.

Welch, H. G., et al., “Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.” The New England Journal of Medicine, 2016. 375 (15): pp. 1438–1447.

. “Early Detection of Cancer.” Harding Center for Risk Literacy. 2018. https://www. harding-center.mpg.de/en/fact-boxes/early-detection-of-cancer; Pinsky, P. F., P. C. Prorok, and B. S. Kramer, “Prostate Cancer Screening – a Perspective on the Current State of the Evidence.” The New England Journal of Medicine, 2017. 376 (13): pp. 1285–1289; “Prostate-Specific Antigen-Based Screening for Prostate Cancer: A Systematic Evidence Review for the U. S. Preventive Services Task Force,” in Evidence Synthesis Number 154 , 2017.

Fraser, M., et al., “Genomic Hallmarks of Localized, Non-Indolent Prostate Cancer.” Nature, 2017. 541 (7637): pp. 359–364.

Pinsky, Prorok, and Kramer, “Prostate Cancer Screening.” The New England Journal of Medicine, 2017.

Ahn, H. S., H. J. Kim, and H. G. Welch, “Korea’s Thyroid-Cancer ‘Epidemic’ – Screening and Overdiagnosis.” The New England Journal of Medicine, 2014. 371 (19): pp. 1765–1767.

Welch, H. G., “Cancer Screening, Overdiagnosis, and Regulatory Capture.” JAMA Internal Medicine, 2017. 177 (7): pp. 915–916.